1-20 of 59
Li Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First report: A novel deep intronic mutation and treatment using hetrombopag olamine of a patient with MYH9 syndrome and immune thrombocytopenia

Free
Yanqing Tan, Weiyu Kong, Haihao Shen, Peng Shan, Xingyu Wang, Jingyi Hu, Yingli Ren, Zhimin Zhai, Li Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 4824.
https://doi.org/10.1182/blood-2025-4824
Published: 2025
Journal Articles

Olverembatinib (HQP1351) demonstrates efficacy vs. best available therapy (BAT) in patients (pts) with tyrosine kinase inhibitor (TKI)-resistant chronic-Phase chronic myeloid leukemia (CML-CP) in a registrational randomized Phase 2 trial: Up to 4-year follow-up including patients without T315I mutations

Free
Qian Jiang, Zongru Li, Yanli Zhang, Yu Hu, Weiming Li, Yongping Song, Junmin Li, Li Zhou, Bingcheng LIU, Xiaoli Liu, Na Xu, Suning Chen, Zhenfang LIU, Huangling Zhu, Jie Jin, He Huang, Sixuan Qian, Li Meng, Xin Du, Xielan Zhao, Sujun Gao, Yang Liang, Ming Hou, Wei Wang, Zi Chen, Qian Niu, Lichuang Men, Dajun Yang, Yifan Zhai, Xiaojun Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3788.
https://doi.org/10.1182/blood-2025-3788
Published: 2025
Journal Articles

Preliminary pharmacokinetic and MRD results from AML patients treated with 7- and 14-day dosing schedule of emavusertib added to combination therapy with azacitidine and venetoclax

Free
Cristina Papayannidis, Ulf Schnetzke, Maximilian Fleischmann, Adolfo De La Fuente Burguera, Klaus Metzeler, Maureen Lane, Li Zhou, Ahmed Hamdy, Claudio Cerchione
Journal: Blood
Blood (2025) 146 (Supplement 1): 5201.
https://doi.org/10.1182/blood-2025-5201
Published: 2025
Journal Articles

A single-center retrospective study of ixazomib-based regimens as maintenance therapy in newly diagnosed multiple myeloma

Free
Yang Yang, Lin Luo, Zhongqing Li, Li Zhou, Rongrong Liu, Jun Luo
Journal: Blood
Blood (2025) 146 (Supplement 1): 7593.
https://doi.org/10.1182/blood-2025-7593
Published: 2025
Journal Articles

Proteomic study of extracellular vesicles reveals novel biomarkers for pathogenesis of immune thrombotic thrombocytopenic purpura

Free
Li Zhou, Ling Chen, Monish Kumar, Sivasankar Chandran, Malay K. Basu, Xinyang Zhao, Navneet K. Dhillon, X. Long Zheng
Journal: Blood
Blood (2025) 146 (Supplement 1): 4873.
https://doi.org/10.1182/blood-2025-4873
Published: 2025
Journal Articles

A low-cost Clinical Prediction model for identifying female hemophilia carriers and women and girls with hemophilia (WGH) in central China

Free
Li Zhou, Wan Jiarui, An Xinyu, Yao Tingyao, He Yangfan, Long Pinpin, Gu Yan, Yujie Zuo
Journal: Blood
Blood (2025) 146 (Supplement 1): 1292.
https://doi.org/10.1182/blood-2025-1292
Published: 2025
Journal Articles

Long-term outcomes with emicizumab prophylaxis in patients with hemophilia a in China

Free
Yuan Xu, Ying Wang, Ningling Wang, Liya He, Jing Ling, Mingwei Jin, Bingshou Xie, Shaohua Le, Meijuan Huang, Jie Peng, Hongbo Cheng, Jiao Jin, Li Zhou, Zeping Zhou, Can Gai, Yujing Zhang, Mei Sun, Xiaojing Li, Jie Yin, Yanli Cheng, Ailing Xue, Weiqun Xu, Hong Han, Fuhua Zhang, Weiguo Zhu, Shen He, Hua Zhou, Lei Zhang, Feng Xue, Renchi Yang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1287.
https://doi.org/10.1182/blood-2025-1287
Published: 2025
Journal Articles

Development of Allogeneic Dual-Targeting CD19/BCMA CAR-T Cell Therapeutics Using ALL-in-One Site-Specific Integration Technology for Autoimmune Diseases

Free
Zhu Li, Yaling Zheng, Huanyu Wang, Chao Zhang, Li Liu, Lulu Lv, Li Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 4785.
https://doi.org/10.1182/blood-2024-199874
Published: 2024
Journal Articles

Development of a Novel Allogeneic Super -Γδ T Cell Therapy for Acute Myeloid Leukemia and Multiple Tumors

Free
Hanlu Wang, Li Liu, Chao Zhang, Junxiao Gao, Lulu Lv, Li Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 2058.
https://doi.org/10.1182/blood-2024-201322
Published: 2024
Journal Articles

Hemophagocytic Syndrome Associated with CAR-T Cell Therapy

Free
Yanqing Tan, Li Zhou, Zhimin Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 7198.
https://doi.org/10.1182/blood-2024-199969
Published: 2024
Journal Articles

Safety and Efficacy of Allogeneic NKG2D NKR-NK for Acute Myeloid Leukemia

Free
Li Zhou, Haihao Shen, Fang Fang, Ming Zhang, Zuhong Hu, Congmiao Wu, Qianshan Tao, Yingwei Li, Fan Wu, Ying Pan, Zhitao Wang, Weihua Xiao, Zhimin Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 7202.
https://doi.org/10.1182/blood-2024-201973
Published: 2024
Journal Articles

Engineering Neutralization-Resistant Oncolytic Vaccinia Virus for Effective Treatment of Multiple Myeloma

Free
Li Zhou, Xiaotong Song, Zhimin Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 4643.
https://doi.org/10.1182/blood-2024-204391
Published: 2024
Journal Articles

Analysis of Genetic Test Results of 47 Hemophiliacs in Anhui and Nearby Areas in China

Free
Zhengyi Cheng, Ziyue Zhang, Li Zhou, Zhimin Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 5490.
https://doi.org/10.1182/blood-2024-205317
Published: 2024
Journal Articles

Investigation of the Impact of Medication on the Mental Health of Hemophiliacs

Free
Zhengyi Cheng, Ziyue Zhang, Li Zhou, Guojing Yuan, Mengyue Zhang, Haihao Shen, Xia Niu, Zhimin Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 3713.
https://doi.org/10.1182/blood-2024-202048
Published: 2024
Journal Articles

Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China

Free
Mengyao Yuan, Li Zhou, Xin Du, Jianyu Weng, Linhua Yang, Yanping Ma, Shasha Zhao, Zhenfang Liu, Qin Wen, Qingxian Bai, Xianqi Feng, Yanqiu Han, Aifang Li, Chunshui Liu, Qing Leng, Li Meng, Baohong Wang, Xuehong Ran, Xiaodong Wang, Haiguo Zhang, Yun Zeng, Yanli Zhang, Qian Jiang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1767.
https://doi.org/10.1182/blood-2024-206453
Published: 2024
Journal Articles

Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis

Free
Xiaoshuai Zhang, Lu Yu, Li Zhou, Yanli Zhang, Huanling Zhu, Bingcheng Liu, Xin Du, Xiaodong Wang, Linhua Yang, Yanping Ma, Li Meng, Yanqing Zhang, Guohui Li, Lijie Yang, Baohong Wang, Xuehong Ran, Jian Huang, Qin Wen, Yan Wen, Yuxia Zhao, Yu Zhu, Yanqiu Han, Zhenfang Liu, Xin Du, Jianyu Weng, Qian Jiang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4529.
https://doi.org/10.1182/blood-2024-203533
Published: 2024
Journal Articles

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Free
Clinical Trials & Observations
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Zhang, Na Xu, Robert Peter Gale, Weiming Li, Xiaoli Liu, Huanling Zhu, Ling Pan, Yunfan Yang, Hai Lin, Xin Du, Rong Liang, Chunyan Chen, Xiaodong Wang, Guohui Li, Zhuogang Liu, Yanqing Zhang, Zhenfang Liu, Jianda Hu, Chunshui Liu, Fei Li, Wei Yang, Li Meng, Yanqiu Han, Li’e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Suning Chen, Huiying Qiu, Lijie Yang, Xiuli Sun, Hui Sun, Li Zhou, Zelin Liu, Danyu Wang, Jianxin Guo, Liping Pang, Qingshu Zeng, Xiaohui Suo, Weihua Zhang, Yuanjun Zheng, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2024) 144 (18): 1951–1961.
https://doi.org/10.1182/blood.2024024761
Published: 2024
Includes: Supplemental data
Journal Articles

Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

Free
Qian Jiang, Zongru Li, Gongli Zhang, Yu Hu, Weiming Li, Yongping Song, Junmin Li, Li Zhou, Bingcheng Liu, Xiaoli Liu, Na Xu, Suning Chen, Zhenfang Liu, Huanling Zhu, Jie Jin, He Huang, Sixuan Qian, Li Meng, Xin Du, Xielan Zhao, Sujun Gao, Yang Liang, Ming Hou, Wei Wang, Zi Chen, Qian Niu, Lichuang Men, Dajun Yang, Yifan Zhai, Xiaojun Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 869.
https://doi.org/10.1182/blood-2023-187740
Published: 2023
Journal Articles

Developing “Off-the-Shelf” CLL1 CAR-DNT Therapeutics for the R/R Acute Myeloid Leukemia

Free
Xu Beilei, Chao Zhang, Junxiao Gao, Zhu Li, Shengzhen Ding, Li Liu, Hang Zhang, Lulu Lyu, Li Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 3442.
https://doi.org/10.1182/blood-2023-173608
Published: 2023
Journal Articles

HDAC3 Is Required for Pathognomonic Features of Langerhans Cell Histiocytes

Free
Peter Dimitrion, Jugmohit Toor, James Ge, Qiyan Wang, Carl E Allen, Li Zhou, Qing-Sheng Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 676.
https://doi.org/10.1182/blood-2023-185195
Published: 2023